Sonothera
4 known investors
SonoThera develops a nonviral, ultrasound-mediated gene delivery technology to safely deliver genetic material to targeted sites in the body. The company addresses limitations in existing genetic medicine approaches for patients across various therapeutic applications.
BiotechDeep TechMedical Devices
Investors · 4
In the news
- Can ultrasound treat Duchenne? Sonothera raises millions to find out | STATstatnews.com · 2026